Candida albicans versus non-albicans intensive care unit-acquired bloodstream infections: differences in risk factors and outcome.
The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: In this study we sought to identify differences in risk factors and outcome of critically ill patients with Candida albicans and non-albicans candidemia. METHODS: Nonimmunosuppressed, nonneutropenic patients with candidemia diagnosed after intensive care unit (ICU) admission were included in a prospective observational study in a medical-surgical ICU at a tertiary academic hospital in Athens, Greece. RESULTS: During the study period (January 2001 to December 2005), 56 candidemia episodes in 1037 ICU admissions were included (5.4%). Of these patients, 36/56 (64.3%) had candidemia due to C. albicans and 20/56 (35.7%) due to non-albicans species (8/56 [14.3%] C. glabrata, 6/56 [10.7%] C. tropicalis, 3/56 [5.4%] C. parapsilosis, 1/56 [1.8%] C. lusitaniae, 1/56 [1.8%] C. krusei and 1/56 [1.8%] C. dubliniensis). Administration of glucocorticosteroids, central venous catheter placement, and preexisting candiduria were independently associated with candidemia due to C. non-albicans species (Odds ratio [OR]: 45.1, 95% confidence interval [CI]: 3.0-669.9; OR: 26.2, 95% CI: 2.1-334.8; and OR: 16.5, 95% CI: 1.6-173.9, respectively). The treatment response rate differed significantly between patients with C. albicans and patients with C. non-albicans bloodstream infections (29/36 [80.6%] vs 9/20 [45%], P = 0.006). Overall mortality was higher in patients with non-albicans species than C. albicans bloodstream infections (18/20 [90%] vs 19/36 [52.8%], P = 0.005). Multivariable logistic regression analysis revealed that candidemia due to non-albicans species was independently associated with death (OR: 6.7, 95% CI: 1.2-37.7). CONCLUSIONS: In the subset of critically ill nonimmunosuppressed patients, candidemia caused by non-albicans species occurred more frequently in those with medical devices or receiving steroids. Candidemia due to non-albicans species was also associated with higher mortality.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These species exhibit higher levels of resistance to antifungal medications and might be associated with higher mortality than C. albicans (18).”
From Population-Based Active Surveillance for Culture-Confirmed Candidemia — Four Sites, United States, 2012–2016 (2019) · cites this paper as [18]
In the citing paper
“Compared with C. albicans, these species more frequently exhibit antifungal resistance and might be associated with higher mortality rates for patients with candidemia (12–14).”
From Population-Based Active Surveillance for Culture-Confirmed Candidemia — 10 Sites, United States, 2017–2021 (2025) · cites this paper as [12]
In the citing paper
“a prospective study in a medical-surgical ICU suggested that candidemia due to non-albicans species was associated with higher mortality [16].”
From Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: part I. Epidemiology and diagnosis (2009) · cites this paper as [16]
Citations
Cites
Nosocomial infections in medical intensive care units in the United States
Richards, M. J., Edwards, J. R., Culver, D. H., & Gaynes, R. P. (1999) · Critical Care Medicine · doi:10.1097/00003246-199905000-00020 · Cited by 1,565
Attributable Mortality of Nosocomial Candidemia, Revisited
Gudlaugsson, O., Gillespie, S., Lee, K., Berg, J. V., Hu, J., Messer, S., Herwaldt, L., Pfaller, M., & Diekema, D. (2003) · Clinical Infectious Diseases · doi:10.1086/378745 · Cited by 1,140
Pappas, P. G., Rex, J. H., Lee, J., Hamill, R. J., Larsen, R. A., Powderly, W., Kauffman, C. A., Hyslop, N., Mangino, J. E., Chapman, S., et al. (2003) · Clinical Infectious Diseases · doi:10.1086/376906 · Cited by 845
Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance
Krcmery, V., & Barnes, A. J. (2002) · Journal of Hospital Infection · doi:10.1053/jhin.2001.1151 · Cited by 733 · cited 2×
“albicans, varying from 15% to 35%.(11) However, there are very few”
BackgroundTrick, W. E., Fridkin, S. K., Edwards, J. R., Hajjeh, R. A., Gaynes, R. P., & Hospitals, T. N. N. I. S. S. (2002) · Clinical Infectious Diseases · doi:10.1086/342300 · Cited by 660
Tortorano, A. M., Peman, J., Bernhardt, H., Klingspor, L., Kibbler, C. C., Faure, O., Biraghi, E., Canton, E., Zimmermann, K., Seaton, S., et al. (2004) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-004-1103-y · Cited by 509
Epidemiological trends in nosocomial candidemia in intensive care
Bassetti, M., Righi, E., Costa, A., Fasce, R., Molinari, M. P., Rosso, R., Pallavicini, F. B., & Viscoli, C. (2006) · BMC Infectious Diseases · doi:10.1186/1471-2334-6-21 · Cited by 332
Attributable mortality of candidemia: a systematic review of matched cohort and case-control studies
Falagas, M. E., Apostolou, K. E., & Pappas, V. D. (2006) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-006-0159-2 · Cited by 294
Self-citationPfaller, M. A., Jones, R. N., Doern, G. V., Sader, H. S., Hollis, R. J., Messer, S. A., & Group, F. T. S. P. (1998) · Journal of Clinical Microbiology · doi:10.1128/jcm.36.7.1886-1889.1998 · Cited by 281
Viudes, A., Pemán, J., Cantón, E., Úbeda, P., López-Ribot, J., & Gobernado, M. (2002) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-002-0822-1 · Cited by 250
Candida glabrata Fungemia: Experience in a Tertiary Care Center
Malani, A., Hmoud, J., Chiu, L., Carver, P. L., Bielaczyc, A., & Kauffman, C. A. (2005) · Clinical Infectious Diseases · doi:10.1086/432939 · Cited by 184
Nosocomial Candidemia in Non-Neutropenic Patients at an Italian Tertiary Care Hospital
Luzzati, R., Amalfitano, G., Lazzarini, L., Soldani, F., Bellino, S., Solbiati, M., Danzi, M. C., Vento, S., Todeschini, G., Vivenza, C., et al. (2000) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s100960000325 · Cited by 179
Fluconazole prophylaxis in critically ill surgical patients: A meta-analysis*
Shorr, A. F., Chung, K., Jackson, W. L., Waterman, P. E., & Kollef, M. H. (2005) · Critical Care Medicine · doi:10.1097/01.ccm.0000178352.14703.49 · Cited by 166
Systemic candidiasis in intensive care units: A multicenter, matched-cohort study
Leleu, G., Aegerter, P., & Guidet, B. (2002) · Journal of Critical Care · doi:10.1053/jcrc.2002.35815 · Cited by 160
Secular Trends of Candidemia Over 12 Years in Adult Patients at a Tertiary Care Hospital
GARBINO, J., KOLAROVA, L., ROHNER, P., LEW, D., PICHNA, P., & PITTET, D. (2002) · Medicine · doi:10.1097/00005792-200211000-00003 · Cited by 143
Risk Factors for Candida tropicalis Fungemia in Patients with Cancer
Kontoyiannis, D. P., Vaziri, I., Hanna, H. A., Boktour, M., Thornby, J., Hachem, R., Bodey, G. P., & Raad, I. I. (2001) · Clinical Infectious Diseases · doi:10.1086/323812 · Cited by 143 · cited 1×
“, but also to a failure of host-defense mechanisms and to complications associated with the patient’s underlying disease.(35) The more severely ill patients are at higher risk for Candida infection and have a worse prognosis.”
BackgroundShifting patterns in the epidemiology of nosocomial Candida infections
Snydman, D. R. (2003) · Chest · doi:10.1378/chest.123.5_suppl.500s · Cited by 142
Risk factors for fatal candidemia caused by Candida albicans and non-albicans Candida species
Cheng, M.-F., Yang, Y.-L., Yao, T.-J., Lin, C.-Y., Liu, J.-S., Tang, R.-B., Yu, K.-W., Fan, Y.-H., Hsieh, K.-S., Ho, M., et al. (2005) · BMC Infectious Diseases · doi:10.1186/1471-2334-5-22 · Cited by 136
Vardakas, K. Z., Michalopoulos, A., & Falagas, M. E. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05727.x · Cited by 129
Self-citationMacphail, G. L. P., Taylor, G. D., Buchanan‐Chell, M., Ross, C., Wilson, S., & Kureishi, A. (2002) · Mycoses · doi:10.1046/j.1439-0507.2002.00741.x · Cited by 119
Candidemia in a Tertiary Care Hospital: Epidemiology and Factors Influencing Mortality
Valle, H. A., Acha, O., García-Palomo, J. D., Fariñas-Álvarez, C., Fernández-Mazarrasa, C., & Fariñas, M. C. (2003) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-003-0890-x · Cited by 113 · cited 1×
“In previous publications, mortality in patients with candidemia has been reported to be up to 80%.(32) Other studies in candidemic patients have also reported a considerable attributable mortality in patients with candidemia.”
BackgroundPfaller, M. A., Jones, R. N., Marshall, S. A., Coffman, S. L., Hollis, R. J., Edmond, M. B., & Wenzel, R. P. (1997) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(97)00064-3 · Cited by 110
Trick, W. E., & Fridkin, S. K. (2002) · Cited by 103
Risk Factors for Nosocomial Candiduria Due to Candida glabrata and Candida albicans
Harris, A. D., Castro, J., Sheppard, D. C., Carmeli, Y., & Samore, M. H. (1999) · Clinical Infectious Diseases · doi:10.1086/520460 · Cited by 95
Antifungal resistance in non- albicans Candida species
Collin, B. A., Clancy, C. J., & Nguyen, M. H. (1999) · Drug Resistance Updates · doi:10.1054/drup.1998.0059 · Cited by 94
Vardakas, K. Z., Samonis, G., Michalopoulos, A., Soteriades, E. S., & Falagas, M. E. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000208357.05675.c3 · Cited by 91 · cited 2×
“DM 14 (38.9) 7 (35) 0.77 Glucocorticosteroids 8 (22.2) 12 (60) 0.005 TPN 16 (44.4) 15 (75) 0.03 Prior antibiotics 36 (100) 20 (100) 1.0 CVC 28 (77.8) 20 (100) 0.02 Candiduria 7 (19.4) 14 (70) 0.001 Antifungal prophylaxis 16 (44.4) 8 ( 40 ) 0.75 Renal failure 10 (27.8) 6 (30) 0.86”
InfluentialSelf-citationPagano, L., Antinori, A., Ammassari, A., Mele, L., Nosari, A., Melillo, L., Martino, B., Sanguinetti, M., Equitani, F., Nobile, F., et al. (1999) · European Journal of Haematology · doi:10.1111/j.1600-0609.1999.tb01120.x · Cited by 88
Miguel, L. G. S., Cobo, J., Otheo, E., Sánchez-Sousa, A., Abraira, V., & Moreno, S. (2005) · Infection Control & Hospital Epidemiology · doi:10.1086/502582 · Cited by 83
Correlation between candiduria and departmental antibiotic use
Weinberger, M., Sweet, S., Leibovici, L., Pitlik, S. D., & Samra, Z. (2003) · Journal of Hospital Infection · doi:10.1053/jhin.2002.1354 · Cited by 78
Outcome in critically ill patients with candidal fungaemia: Candida albicans vs. Candida glabrata
Blot, S., Vandewoude, K., Hoste, E., Poelaert, J., & Colardyn, F. (2001) · Journal of Hospital Infection · doi:10.1053/jhin.2000.0918 · Cited by 73 · cited 1×
“Other studies in candidemic patients have also reported a considerable attributable mortality in patients with candidemia.(33,34) Candida infection is not solely related to the pathogenicity of the Candida spp.”
BackgroundJoseph Baran Jr, B. M. (2001) · Scandinavian Journal of Infectious Diseases · doi:10.1080/003655401750065544 · Cited by 70
Safdar, A., Perlin, D. S., & Armstrong, D. (2002) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(02)00423-6 · Cited by 69
Principles and practice of clinical mycology
Kibbler, C. C., Mackenzie, D. W. R., & Odds, F. C. (1996) · UCL Discovery (University College London) · Cited by 59
Candidemia: The Impact of Antifungal Prophylaxis in a Surgical Intensive Care Unit
Swoboda, S. M., Merz, W. G., & Lipsetta, P. A. (2003) · Surgical Infections · doi:10.1089/109629603322761409 · Cited by 54
Non-albicans Candida is the most common cause of candidemia in pediatric cancer patients
Mullen, C. A., El-Baki, H. A., samir, H., Tarrand, J. J., & Rolston, K. V. I. (2003) · Supportive Care in Cancer · doi:10.1007/s00520-003-0453-9 · Cited by 46
Candidemia in patients with diabetes mellitus: epidemiology and predictors of mortality
Bader, M. S., Lai, S. M., Kumar, V., & Hinthorn, D. (2004) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540410021126 · Cited by 37
[Epidemiology of candidemia in Spain - Multicenter study]
Pemán, J., Cantón, E., Orero, A., Viudes, A., Frasquet, J., & Gobernado, M. (2002) · PubMed · Cited by 34
Frequency, pathogenicity and microbiologic outcome of non-Candida albicans candiduria
Occhipinti, D. J., Gubbins, P. O., Schreckenberger, P. C., & Danziger, L. H. (1994) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf01974635 · Cited by 32
Colombo, A. L., Nakagawa, Z. M. B., Valdetaro, F., Branchini, M. L. M., Kusano, E. J. U., & Nucci, M. (2003) · Medical Mycology · doi:10.1080/1369378031000137198 · Cited by 32 · cited 1×
“unchanged comparative incidence (statistically non significant) during the 5-yr study period.(22)”
BackgroundCandida colonization in patients with esophageal disease: a prospective clinical study
Bonavina, L., Incarbone, R., Reitano, M., Tortorano, A. M., Viviani, M. A., & Peracchia, A. (2003) · Diseases of the Esophagus · doi:10.1046/j.1442-2050.2003.00297.x · Cited by 24 · cited 2×
“C. glabrata 1 (14.3) 2 (20) 2 (16.7) 1 (7.7) 2 (14.3) 8 (14.3) C. tropicalis 2 ( 20 ) 1 (8.3) 2 (15.4) 1 (7.1) 6 (10.7) C. parapsilosis 1 (14.3) 1 (8.3) 1 (7.7) 3 (5.4) C. lusitaniae 1 (7.1) 1 (1.8) C. krusei 1 (8.3) 1 (1.8) C. dubliniensis 1 (7.1) 1 (1.8)”
InfluentialCandidiasis in the Intensive Care Unit
Sobel, J. D., & Vazquez, J. (2003) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-2003-37921 · Cited by 17
Küçükateş, E., Erturan, Z., Susever, S., & Yeğenoğlu, Y. (2005) · Apmis · doi:10.1111/j.1600-0463.2005.apm_06.x · Cited by 16
Candidemia in the Surgical Intensive Care Unit
Krcmery, V., & Babela, R. (2002) · Clinical Infectious Diseases · doi:10.1086/340529 · Cited by 14 · cited 1×
“DM 14 (38.9) 7 (35) 0.77 Glucocorticosteroids 8 (22.2) 12 (60) 0.005 TPN 16 (44.4) 15 (75) 0.03 Prior antibiotics 36 (100) 20 (100) 1.0 CVC 28 (77.8) 20 (100) 0.02 Candiduria 7 (19.4) 14 (70) 0.001 Antifungal prophylaxis 16 (44.4) 8 (40) 0.75 Renal failure 10 (27.8) 6 ( 30 ) 0.86”
InfluentialCandidal infection is uncommon in acute oesophagitis: evidence from a non-selected DGH population
Baldwin, L., & Poller, D. N. (2000) · Journal of Clinical Pathology · doi:10.1136/jcp.53.1.84 · Cited by 1
Cited by
Epidemiology and risk factors for invasive candidiasis
Yapar, N. (2014) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s40160 · Cited by 610
“A study conducted between 2001 and 2005 in Greece identified glucocorticoid use, presence of central venous catheters, and candiduria as independent risk factors for infections due to non-albicans species.(30) A similar study conducted in the USA between 1995 and 2005 reported that the duration of fluconazole treatmen…”
Background-D-Glucan Assay for the Diagnosis of Invasive Fungal Infections: A Meta-analysis
Karageorgopoulos, D. E., Vouloumanou, E. K., Ntziora, F., Michalopoulos, A., Rafailidis, P. I., & Falagas, M. E. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq206 · Cited by 538
“dependent on various types of supportive care [4, 5].”
BackgroundSelf-citationInfection Risk and Safety of Corticosteroid Use
Youssef, J., Novosad, S. A., & Winthrop, K. L. (2016) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2015.08.004 · Cited by 459
Antifungal drug resistance among Candida species: mechanisms and clinical impact
Sanguinetti, M., Posteraro, B., & Lass‐Flörl, C. (2015) · Mycoses · doi:10.1111/myc.12330 · Cited by 394
Morbidity and mortality of candidaemia in Europe: an epidemiologic meta-analysis
Koehler, P., Stecher, M., Cornely, O. A., Koehler, D., Vehreschild, M. J. G. T., Bohlius, J., Wisplinghoff, H., & Vehreschild, J. J. (2019) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2019.04.024 · Cited by 336
Metadata
- Authors
- Dimopoulos, G., Ntziora, F., Rachiotis, G., Armaganidis, A., & Falagas, M. E.
- Affiliations
- Alfa Institute of Biomedical Sciences (GR)
- Sotiria General Hospital (GR)
- University General Hospital Attikon (GR)
- Tufts University (US)
- Corresponding author
- Rachiotis, George
- Venue
- Anesthesia & Analgesia
- Published
- 2008-02
- Volume
- 106
- Issue
- 2
- Pages
- 523-529
- ISSN
- 0003-2999 (ISSN-L)
- OpenAlex
- W1986442140
- Cited by
- 189
- References
- 44
- Citations by year
- 2025: 4 · 2024: 3 · 2023: 6 · 2022: 10 · 2021: 5 · 2020: 13 · 2019: 12 · 2018: 3 · 2017: 9 · 2016: 7 · 2015: 20 · 2014: 14 · 2013: 9 · 2012: 12
- FWCI
- 13.28
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Anesthesia & Analgesia (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Nosocomial Infections in ICU
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Infective Endocarditis Diagnosis and Management
- Keywords
- Candida albicans, candidemia, critically ill patients, risk factors, glucocorticoids, central venous catheters, candiduria, Candida glabrata, Candida tropicalis, Candida parapsilosis, treatment response, mortality
- MeSH terms
- Aged, Aged, 80 and over, Candida albicans, Candidiasis, Cross Infection, Female, Glucocorticoids, Humans, Intensive Care Units, Male, Middle Aged, Prospective Studies, Risk Factors, Fungemia, Critical Illness, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.